GMED - Globus Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMED is currently covered by 14 analysts with an average price target of $82.34. This is a potential upside of $11.84 (16.79%) from yesterday's end of day stock price of $70.5.

Globus Medical's activity chart (see below) currently has 210 price targets and 213 ratings on display. The stock rating distribution of GMED is 44.12% HOLD, 52.94% BUY and 2.94% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.7% with an average time for these price targets to be met of 294.15 days.

Highest price target for GMED is $115, Lowest price target is $80, average price target is $97.11.

Most recent stock forecast was given by RICHARD NEWITTER from TRUIST on 11-Apr-2025. First documented stock forecast 17-Jun-2013.

Currently out of the existing stock ratings of GMED, 30 are a HOLD (44.12%), 36 are a BUY (52.94%), 2 are a SELL (2.94%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$80

$8.09 (11.25%)

$82

25 days ago
(11-Apr-2025)

24/27 (88.89%)

$7.41 (10.21%)

347

Hold

1 months 18 days ago
(18-Mar-2025)

3/3 (100%)

$10.44 (17.24%)

499

Buy

$103

$31.09 (43.23%)

$93

2 months 12 days ago
(24-Feb-2025)

21/22 (95.45%)

$22.98 (28.72%)

359

Hold

2 months 12 days ago
(24-Feb-2025)

1/1 (100%)

$4.73 (18.01%)

469

Buy

$94

$22.09 (30.72%)

$92

2 months 15 days ago
(21-Feb-2025)

8/9 (88.89%)

$13.72 (17.09%)

122

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMED (Globus Medical) average time for price targets to be met?

On average it took 294.15 days on average for the stock forecasts to be realized with a an average price target met ratio 92.7

Which analyst has the current highest performing score on GMED (Globus Medical) with a proven track record?

JASON WITTES

Which analyst has the most public recommendations on GMED (Globus Medical)?

Jason Wittes has 9 price targets and 8 ratings on GMED

Which analyst is the currently most bullish on GMED (Globus Medical)?

Jason Wittes with highest potential upside - $43.09

Which analyst is the currently most reserved on GMED (Globus Medical)?

Steven Lichtman with lowest potential downside - -$48.91

Globus Medical in the News

Globus Medical (GMED) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company’s earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates....

4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates

The first-quarter reporting cycle is off to a positive start, with most companies beating on estimates. However, uncertainty about the overall macroeconomic picture continues to be a significant drag on the earnings outlook as a whole, prompting analysts to cut their estimates for future quarters. Meanwhile, the Medical sector’s earnings growth seems to outshine other...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?